These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2955205

  • 1. Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
    Hirvonen E, Lipasti A, Mälkönen M, Kärkkäinen J, Nuntila J, Timonen H, Manninen V.
    Maturitas; 1987 Apr; 9(1):69-79. PubMed ID: 2955205
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of oestradiol valerate plus two different progestogens on serum lipids during post-menopausal replacement therapy.
    Makkonen M, Saarikoski S, Penttilä I.
    Maturitas; 1991 Dec; 14(1):43-8. PubMed ID: 1791771
    [Abstract] [Full Text] [Related]

  • 4. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK, Anklesaria BS, Ganatra AM, Pinto R.
    Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
    [Abstract] [Full Text] [Related]

  • 5. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Jensen J, Riis BJ, Strøm V, Christiansen C.
    Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
    [Abstract] [Full Text] [Related]

  • 6. Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
    Vilska S, Punnonen R, Rauramo L.
    Maturitas; 1983 Aug; 5(2):97-104. PubMed ID: 6415365
    [Abstract] [Full Text] [Related]

  • 7. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C.
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [Abstract] [Full Text] [Related]

  • 8. Effect of continuous oestradiol-medroxyprogesterone administration on plasma lipids and lipoproteins.
    Cano A, Fernandes H, Serrano S, Mahiques P.
    Maturitas; 1991 Mar; 13(1):35-42. PubMed ID: 1861641
    [Abstract] [Full Text] [Related]

  • 9. Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate.
    Hellberg D, Nilsson S.
    Maturitas; 1987 Apr; 9(1):103-7. PubMed ID: 2955203
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R, Urdinola J, Onatra W, Sánchez F, Posso H.
    Maturitas; 1999 May 31; 32(1):41-50. PubMed ID: 10423715
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A, Dodin S, Cédrin I, T-Lemay L.
    Clin Endocrinol (Oxf); 1995 Apr 31; 42(4):341-51. PubMed ID: 7750187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins.
    Jensen J, Riis BJ, Christiansen C.
    Br J Obstet Gynaecol; 1987 Feb 31; 94(2):136-41. PubMed ID: 3030392
    [Abstract] [Full Text] [Related]

  • 17. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E, Mälkönen M, Manninen V.
    N Engl J Med; 1981 Mar 05; 304(10):560-3. PubMed ID: 7453723
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with a low-dose combination of estradiol valerate and levonorgestrel. Double-blind comparative study between SH D 386 F and Cyclabil. Effects on symptoms, lipids and endometrial condition.
    Lagrelius A, Fredricsson B, Hirt M, Weintraub L.
    Acta Obstet Gynecol Scand Suppl; 1986 Mar 05; 134():97-101. PubMed ID: 3101396
    [Abstract] [Full Text] [Related]

  • 19. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
    Marslew U, Munk-Nielsen N, Nilas L, Riis BJ, Christiansen C.
    Maturitas; 1994 Oct 05; 19(3):225-37. PubMed ID: 7799829
    [Abstract] [Full Text] [Related]

  • 20. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C, Crook D, Ross D, Cooper A, Whitehead M, Stevenson J.
    Br J Obstet Gynaecol; 1999 Sep 05; 106(9):948-53. PubMed ID: 10492107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.